ArticleBrain sciences2018
Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon.
Article in Brain sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.Medicina (Kaunas, Lithuania) · 2021Pooled it
- Shifting Drug Landscapes in China: A Multilevel Analysis of Traditional vs New Psychoactive Substance Use and Interregional Differences.Substance abuse and rehabilitation · 2026Article
- Severe tremors induced by tiletamine e-cigarette and alcohol use: a case report.Frontiers in psychiatry · 2025Article
- Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review.Healthcare (Basel, Switzerland) · 2024Review
- Akathisia after chronic usage of synthetic cathinones: A case study.Frontiers in psychiatry · 2022Article
- Editorial: Prescribing psychotropics: Misuse, abuse, dependence, withdrawal and addiction, Volume II.Frontiers in psychiatry · 2022Article
- COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis.Brain sciences · 2021Article
- Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction.Frontiers in psychiatry · 2021Article
- Substance-Induced Psychoses: An Updated Literature Review.Frontiers in psychiatry · 2021Review
- What about "Pharming"? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs.Brain sciences · 2020Article
- Analyzing the Open/Deep Web to Better Understand the New/Novel Psychoactive Substances (NPS) Scenarios: Suggestions from CASSANDRA and NPS.Finder Research Projects.Brain sciences · 2020Article
- Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances.Brain sciences · 2020Article
- The clinical challenges of synthetic cathinones.British journal of clinical pharmacology · 2020Article
- COVID-19: The Hidden Impact on Mental Health and Drug Addiction.Frontiers in psychiatry · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the last decade, the emergence of a vast range of new/novel/emerging psychoactive substances (NPS) has progressively changed drug market scenarios, which have shifted from the 'street' to a 'virtual'/online environment. [...].
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.